Arthneeti
SI

Star Imaging

Q4 FY26Healthcare Services

Star Imaging Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

What the Q4 FY26 call signalled

2 of 4 strong

RevenueGood growth
MarginMargins steady
CapexCapex planned
FundraiseNo fundraise planned
Price₹77
Market cap₹134 Cr
P/E7.0

The short version

The company targets revenue growth of 25% to 30% for FY27 and expects this to be consistent over the next 2-3 years. The company expects consistent top-line growth of 25% to 30% for the next 2-3 years (FY27 onward).

From Star Imaging's Q4 FY26 earnings-call transcript · updated 23 Sept 2026.

Revenue & Sales Performance

Good growth
  • The company targets revenue growth of 25% to 30% for FY27 and expects this to be consistent over the next 2-3 years.
  • Revenue guidance for FY28 is around INR 110 to 120 crores.
  • Growth will be driven by expanding diagnostic centre footprint in existing and new locations.
  • Focus on deepening specialised diagnostic capabilities, especially in molecular diagnostics and advanced imaging.
  • New centres are being opened (e.g., Dwarka centre with expected revenue of INR 5-6 crores initially).

2 more points from Star Imaging's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Star Imaging said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • FY27 capex planned at around INR 20 to 25 crores, primarily for equipment purchase and construction of new centres.
  • Recently opened Dwarka Centre involved a capex of approximately INR 14 crores, expected to generate revenue of INR 5-6 crores initially with EBITDA margins around 35-40%.
  • Additional smaller centres under pipeline, such as installation of CT scanners at multiple RG Hospital locations with capex of around INR 2 crores each, expected to break even faster.
  • Management aims for consistent 25-30% top-line growth over next 2-3 years, supported by expansion into new locations and deepening specialized diagnostic capabilities.

2 more points from Star Imaging's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
1Health X Platform
Rev 1Mar 1
2Chandan Healthca
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Star Imaging said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company has ongoing projects and plans to open new centres, including one opening within the next two months.
  • There is mention of having projects in the pipeline, such as installation of CT scanners in multiple locations through tie-ups with hospitals (e.g., RG Hospitals).
  • Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment.
  • Large government tenders may require higher capex (INR 50-60 crores), for projects involving multiple hospitals, implying potential sizable pending orders if such tenders are won.

Continue your research

Others in Healthcare Services this season

  • Suven Life Sciences (Q4 FY26)

    The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su

  • Invicta Diagnostic (Q4 FY26)

    Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…

  • KMC Speciality (Q4 FY26)

    Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…

  • Gaudium IVF (Q4 FY26)

    Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…

Compare:vs Apollo Hospitalsvs Max Healthcarevs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Star Imaging and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Star Imaging Q4 FY26 results?

The company targets revenue growth of 25% to 30% for FY27 and expects this to be consistent over the next 2-3 years. The company expects consistent top-line growth of 25% to 30% for the next 2-3 years (FY27 onward).

What is Star Imaging share price analysis?

Star Imaging currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 7.0 with a market cap of ₹134 Cr. Investors should review the full earnings analysis for detailed insights.

Is Star Imaging planning capital expenditure?

FY27 capex planned at around INR 20 to 25 crores, primarily for equipment purchase and construction of new centres.

Keep Star Imaging on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.